The Canagliflozin Market size is expected to grow at an annual average of 6% during 2021-2027. Canagliflozin, a sodium-glucose co-transporter-2 (SGLT2) inhibitor cardiac metabolic parameters. Type 2 diabetes mellitus (T2DM) is well known as a major public health problem that puts patients at a significant risk of complications including heart disease, retinopathy, nephropathy and neuropathy. Various types of orally administered antihyperglycemic agents have been developed for the treatment of diabetes, and although individual agents may be very effective for some patients, it is still difficult to maintain optimal glycemic control in most patients, resulting in high morbidity and mortality. diabetic population. This is a randomized, double-blind, active control, 3-arm, parallel-group, multicenter to demonstrate the efficacy, safety and tolerability of canagliflozin compared to sulfonylurea (glimepiride) in T2DM patients aged 18 to 80 years. Research. Age not optimally controlled with metformin monotherapy (inclusive). The main research hypothesis is that the study drug will not be inferior to glimepiride as assessed by the change in hemoglobin A1c (HbA1c) from baseline.
(Get 15% Discount on Buying this Report)
Get Sample Copy of Canagliflozin Market at: https://www.orionmarketreports.com/request-sample/?id=72036
The following segmentation are covered in this report:
By Application
- Diabetes
- Heart Disease
- Others
By Type
- 100mg
- 300mg
Company Profile
- Janssen Pharmaceuticals
- Mitsubishi Tanabe Pharma
- Hansoh Pharma
- Hinye
The report covers the following objectives:
- Proliferation and maturation of trade in the global Canagliflozin Market
- The market share of the global Canagliflozin Market supply and demand ratio, growth revenue, supply chain analysis, and business overview.
- Current and future market trends that are influencing the growth opportunities and growth rate of the Canagliflozin Market
- Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Canagliflozin Market
Scope of the report
The research study analyses the Canagliflozin Market industry from 360-degree analysis of the market thoroughly delivering insights into the market for better business decisions, considering multiple aspects some of which are listed below as:
Recent developments
- Market overview and growth analysis
- Import and export overview
- Volume analysis
- Current market trends and future outlook
- Market opportunistic and attractive investment segment
A full report of Canagliflozin Market is available at: https://www.orionmarketreports.com/canagliflozin-market/72036/
Geographic coverage
- North america market size and/or volume
- Latin america market size and/or volume
- Europe market size and/or volume
- Asia-pacific market size and/or volume
- Rest of the world market size and/or volume
Key Questions Answered by Canagliflozin Market Report
- What was the Canagliflozin Market size in 2019 and 2020; what are the estimated growth trends and market forecast (2021-2027)
- What will be the CAGR of Market during the forecast period (2021-2027)?
- Which segments (product type/applications/end-user) were most attractive for investments in 2021? How these segments are expected to grow during the forecast period (2021-2027).
- Which manufacturer/vendor/players in the Canagliflozin Market was the market leader in 2020?
- Overview on the existing product portfolio, products in the pipeline, and strategic initiatives taken by key vendors in the market.
About us:
Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.
Media Contact:
Company name: Orion Market Reports
Contact person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404
